Turtle Creek Wealth Advisors, LLC Shattuck Labs, Inc. Transaction History
Turtle Creek Wealth Advisors, LLC
- $1.12 Trillion
- Q3 2025
A detailed history of Turtle Creek Wealth Advisors, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Turtle Creek Wealth Advisors, LLC holds 12,235 shares of STTK stock, worth $23,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,235Holding current value
$23,491% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STTK
# of Institutions
63Shares Held
30.3MCall Options Held
36KPut Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$12.7 Million1.42% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$10.6 Million0.53% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$8.98 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.12 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $81.4M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...